Search

everythinglearnresearchcommunity

for

Search:↓

Acne is common in women, often hormone-related, negatively affects quality of life, and requires various treatments.

Hormonal imbalances, often indicating conditions like PCOS, are common in women with hard-to-treat acne, and a treatment approach addressing these imbalances may be needed.

Early diagnosis and treatment are key to managing health risks in teens with PCOS.

Hormonal therapy is a treatment option for acne, the only medical treatment for hirsutism, and the most promising for androgenetic alopecia.

Most patients experienced hirsutism again after stopping hormone treatment, indicating long-term treatment is needed to maintain results.

The document suggests that blocking sweat glands with antiperspirants might allow skin-generated hormones to be absorbed, possibly increasing breast and prostate cancer risk.

Lupus can cause hair loss and nail changes, with treatments available for both.

Rare adrenal cancers that secrete androgens or estrogens have a poor prognosis and are treated primarily with surgery.

The document explains that hirsutism, often caused by hormonal issues, can be managed with treatment to improve both physical appearance and mental health.

Finasteride reduces hair growth in women with hirsutism and works better with electrolysis.

Different types of PCOS in Chinese Han women show varying levels of male hormone and metabolic issues.

Finasteride can cause lasting sexual dysfunction, depression, and other side effects, needing more research for treatment.

The medication cyproterone acetate/ethinylestradiol is usually prescribed correctly for acne after other treatments don't work.

Finasteride helps induce ovulation in nonresponder PCOS women.

QR 678 and QR678 Neo treatments are effective for hair loss in women with PCOS.

The review concludes that more research is needed to better improve the health outcomes for people with Polycystic Ovarian Syndrome.

The document concludes that various skin conditions have specific treatments, ranging from antihistamines for urticaria to surgery and medication for tumors and chronic skin diseases.

The conference highlighted new dermatological treatments and emphasized early intervention and addressing conditions lacking evidence-based treatments.

Glucocorticoids and sex hormones affect skin health, with potential for targeted treatments to minimize side effects and treat skin conditions.

The document describes various skin conditions, their features, and treatments but lacks detailed study size information.

Telogen Effluvium is a hair loss condition where treatment involves identifying and managing its triggers.

Early treatment and weight management are important for teenagers with PCOS to reduce symptoms and long-term health risks.

Identifying nonclassic congenital adrenal hyperplasia and carriers of CYP21 mutations is challenging, and genetic counseling is recommended due to their prevalence.

Early treatment of acne is crucial to prevent scarring and psychological effects.

The document concludes that managing PCOS requires a comprehensive approach, including lifestyle changes and medication, to improve symptoms and reduce health risks.

High androgen levels can cause excessive hair growth and may indicate serious health issues, including heart disease and fertility problems.

The document concludes that accurate diagnosis and appropriate management are crucial for treating various hair disorders, which have significant psychological impacts.

Adult female acne is a complex condition that can worsen with menopause, requiring holistic treatment and tailored skincare at different life stages.

Hormonal imbalances are a key cause of missed menstrual periods in women.

PCOS may increase the risk of certain cancers.